Details for Patent: 9,265,893
✉ Email this page to a colleague
Which drugs does patent 9,265,893 protect, and when does it expire?
Patent 9,265,893 protects VICTOZA and is included in one NDA.
Protection for VICTOZA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifteen patent family members in thirteen countries.
Summary for Patent: 9,265,893
| Title: | Injection button |
| Abstract: | A push button connection for an injection device comprising a push button (10) and a driving part (20). The two parts of the push button connection are mounted to each other and is relatively rotatable to each other. In order to minimize the friction occurring between the push button and the driving part when relatively rotated forces are transmitted via a pivot bearing (18, 22). In order also to minimize the effect of forces appearing dislocated from the center line a number of radial bearings (13, 23; 14, 25) having a little friction diameter is provided. |
| Inventor(s): | Hansen; Torben Stroem (Copenhagen V, DK), Wielandt; Jakob Oest (Copenhagen N, DK), Groth; Lars Moerch (Fredensborg, DK) |
| Assignee: | Novo Nordisk A/S (Bagsvaerd, DK) |
| Application Number: | 12/525,976 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,265,893 |
|
Patent Claim Types: see list of patent claims | Device; |
Drugs Protected by US Patent 9,265,893
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk Inc | VICTOZA | liraglutide recombinant | SOLUTION;SUBCUTANEOUS | 022341-001 | Jan 25, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,265,893
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 07101729 | Feb 5, 2007 | |
| PCT Information | |||
| PCT Filed | January 21, 2008 | PCT Application Number: | PCT/EP2008/050624 |
| PCT Publication Date: | August 14, 2008 | PCT Publication Number: | WO2008/095762 |
International Family Members for US Patent 9,265,893
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | E483487 | ⤷ Try a Trial | |||
| Australia | 2008213084 | ⤷ Try a Trial | |||
| Brazil | PI0806854 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
